ClinicalTrials.gg
CompletedNCT07913230ATFVOUpdated Nov 3, 2026

Art Therapy For Violent Offenders

An interventional study of Expressive Arts Therapy in Emotion Dysregulation and Aggressive Behavior in Violent Offenders, sponsored by Shenzhen University. Completed at 1 site in China. Open to male participants aged 20 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by Shenzhen University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 2 years after the study started (first participant enrolled Oct 2024, registered Oct 2026).
Updated Nov 3, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
65
Allocation
Randomized
Ages
20 Years and older
Sex
Male
01

Study summary

This randomized controlled trial evaluated whether an 8-week expressive arts therapy (EAT) program can improve emotion regulation and reduce aggression in male violent offenders incarcerated in a Chinese prison. A total of 65 participants were randomly assigned to an EAT intervention group (n=31) or a routine-care control group (n=34). The program used art, clay, and music to help participants express emotions and reinterpret negative experiences.

02

Conditions studied

  • Emotion Dysregulation and Aggressive Behavior in Violent Offenders

Browse trials for

03

In context

Behavior

1,573 studies on the registry are indexed under Behavior; 313 are open to participants now.

This study's enrollment of 65 is below the median of 120 across 1,197 interventional studies indexed under Behavior.

Browse Behavior studies →

Lead sponsor

Shenzhen University is the lead sponsor of 4 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • male inmates incarcerated in a male prison for violent crimes including intentional homicide, intentional injury, affray, and robbery, aged 20-58 years, with a remaining sentence exceeding 6 months, who screened positive for high alexithymia and difficulties in emotion regulation tendencies (elevated TAS-20 and DERS-16 scores), and who voluntarily agreed to participate and provided written .

Exclusion criteria

Exclusion Criteria:

  • individuals with a diagnosis of antisocial personality disorder or current mental illness diagnoses, illiterate individuals and those unwilling to participate, and, in the IAT data analysis, participants with missing data in any of the three experimental sessions, more than 10% of trials with reaction times >10000 ms or \<300 ms, or mean error rates exceeding 20%.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
65 participants (actual)

Study arms

  • Experimental
    expressive arts therapy group

    Participants in the Expressive Arts Therapy (EAT) group received an 8-week group intervention delivered by qualified expressive arts therapists. The 31 participants were divided into three small groups of approximately 10 members each. The intervention consisted of one two-hour session per week, with each week focusing on a specific theme: Body and Emotions, Stress Volcano, Seeing Emotions, Unspoken Words, Self-Awareness, Life Line, Flow of Life, and Review \& Prospect. The therapy integrated multimodal arts-including painting, clay work, and music-to facilitate emotional expression, bypass verbal defenses, and enhance cognitive reappraisal by helping participants externalize and reinterpret emotional experiences.

    Behavioral: Expressive Arts Therapy

  • No intervention
    control group

    Participants in the control group (n = 34) received routine prison management only and did not participate in the Expressive Arts Therapy (EAT) intervention. However, the prison's routine psychological services remained available to all participants in this group throughout the study period. They completed the same baseline, mid-treatment (4-week), and post-treatment (8-week) assessments as the intervention group.

Interventions

  • BehavioralExpressive Arts Therapy

    The intervention consisted of one two-hour session per week, with each week focusing on a specific theme: Body and Emotions, Stress Volcano, Seeing Emotions, Unspoken Words, Self-Awareness, Life Line, Flow of Life, and Review \& Prospect.

    Also known as: EAT

06

What researchers measure

Primary outcomes

  1. Cognitive Reappraisal Capacity (Picture-Rating Task)

    Cognitive reappraisal capacity was assessed using a computerized picture-rating task programmed in E-Prime 3.0, utilizing 40 negative images selected from the Chinese Affective Picture System. The task consisted of two parts: "rating after viewing" and "rating after cognitive reappraisal." In the "rating after viewing" part, participants rated their emotional response to 20 randomly assigned images. In the "rating after cognitive reappraisal" part, participants were instructed to provide positive interpretations of the depicted persons or scenarios for the remaining 20 images before rating their emotional response. Ratings were made on a 9-point scale ranging from 1 (minimal negative emotion) to 9 (strongest negative emotion). For subsequent administrations (mid- and post-treatment), half of the images were replaced with new ones, while both groups viewed the same image sets at each time point.

    Time frame: Baseline (before the intervention), mid-treatment (after 4 weeks of intervention), and post-treatment (upon completion of the 8-week intervention).

Secondary outcomes

  1. Implicit Violent Attitudes (Implicit Association Test)

    Implicit violent attitudes were measured using the Implicit Association Test (IAT) programmed in E-Prime 3.0, comprising two types of implicit word associations: "self-violence" and "violence-positive." The "self-violence" IAT assessed automatic associations between self-concept and violence by measuring reaction times when pairing self-related words with violence-related attributes, while the "violence-positive" IAT evaluated implicit attitudes toward violence by measuring association speeds between violence-related words and valenced attributes. The test included four critical blocks: block 4 (violence-self + peace-others pairing), block 7 (violence-others + peace-self pairing), block 11 (positive-defend + negative-attack pairing), and block 14 (positive-attack + negative-defend pairing). The "self-violence" IAT effect was calculated by subtracting the mean RT of Block 4 from Block 7, and the "violence-positive" IAT effect by subtracting Block 11's mean RT from Block 14's.

    Time frame: Baseline (0-week), mid-treatment (4-week), and post-treatment (8-week).

  2. Mood States (Visual Analogue Mood Scale, VAMS)

    Mood states were assessed using the Visual Analogue Mood Scale (VAMS), programmed using NET 8.0, which consists of 18 items across four dimensions: somatic state, psychosomatic state, emotional state, and extraversion. Each item presents a pair of antonymous adjectives, and participants rated their current state by clicking on a 100-point continuum between the two descriptors (e.g., 1 = "extremely drowsy" to 100 = "extremely alert"). The scale includes 13 forward-scored and 5 reverse-scored items, with higher composite scores indicating greater positivity in each respective dimension.

    Time frame: Baseline (0-week), mid-treatment (4-week), and post-treatment (8-week).

07

Study locations

1 site
  • School of Psychology, No. C-L3-12, Building Zhiyi, Caohai Campus, Shenzhen University, Nanshan District, Shenzhen City, Guangdong Province
    Shenzhen, Guangdong 518060, China
08

References and documents

Individual participant data

Plan to share: No — The study was conducted with a vulnerable population-incarcerated violent offenders-within a correctional facility. Participants provided informed consent with the assurance that their individual data would remain confidential and would not be shared outside the research team. Furthermore, the prison administration imposed strict data governance requirements, including that all data remain under institutional control and be used solely for the purposes of this approved study. Therefore, access to the data is restricted to the principal investigators and authorized research personnel, and de-identified data may only be made available to qualified researchers upon reasonable request to the corresponding author, subject to approval from the Ethics Committee of Shenzhen University and the prison administration, and in compliance with applicable privacy and institutional regulations.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07913230
Lead sponsor
Shenzhen University
Responsible party
Jialin Fan (Principal Investigator, Shenzhen University) — Principal investigator
First posted
Nov 3, 2026
Start date
Oct 1, 2024
Primary completion
Feb 14, 2025
Completion
Feb 14, 2025
Last update
Nov 3, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion